These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 628003)
1. Adriamycin analogues. 2. Synthesis of 13-deoxyanthracyclines. Smith TH; Fujiwara AN; Henry DW J Med Chem; 1978 Mar; 21(3):280-3. PubMed ID: 628003 [TBL] [Abstract][Full Text] [Related]
2. Adriamycin analogues. Preparation and antitumor evaluation of 7-O-(beta-D-glucosaminyl)daunomycinone and 7-O-(beta-D-glucosaminyl)adriamycinone and their N-trifluoroacetyl derivatives. Israel M; Murray RJ J Med Chem; 1982 Jan; 25(1):24-8. PubMed ID: 7086817 [TBL] [Abstract][Full Text] [Related]
4. Syntheses and antitumor activities of 7-O-(6-deoxy-2-O-methyl-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone. Takagi Y; Kobayashi N; Tsuchiya T; Umezawa S; Takeuchi T; Komuro K; Nosaka C J Antibiot (Tokyo); 1989 Aug; 42(8):1318-20. PubMed ID: 2759915 [No Abstract] [Full Text] [Related]
5. Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone. Arcamone F; Penco S; Vigevani A; Redaelli S; Franchi G; DiMarco A; Casazza AM; Dasdia T; Formelli F; Necco A; Soranzo C J Med Chem; 1975 Jul; 18(7):703-7. PubMed ID: 168385 [TBL] [Abstract][Full Text] [Related]
6. Adriamycin analogues. Preparation and biological evaluation of some N-perfluoroacyl analogues of daunorubicin, adriamycin, and N-(trifluoroacetyl)adriamycin 14-valerate and their 9,10-anhydro derivatives. Israel M; Potti G J Med Chem; 1982 Feb; 25(2):187-91. PubMed ID: 7057426 [TBL] [Abstract][Full Text] [Related]
7. Syntheses and antitumor activities of 7-O-(3-amino-2,3,6-trideoxy-2-fluoro-alpha-L-talopyranosyl)daunomvcinone and -adriamycinone. Takagi Y; Park H; Tsuchiya T; Umezawa S; Takeuchi T; Komuro K; Nosaka C J Antibiot (Tokyo); 1989 Aug; 42(8):1315-7. PubMed ID: 2759914 [No Abstract] [Full Text] [Related]
8. Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moiety. Di Marco A; Casazza AM; Dasdia T; Necco A; Pratesi G; Rivolta P; Velcich A; Zaccara A; Zunino F Chem Biol Interact; 1977 Dec; 19(3):291-302. PubMed ID: 597963 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of antitumor-active 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl)-daunomycinone and -adriamycinone. Ok K; Takagi Y; Tsuchiya T; Umezawa S; Umezawa H Carbohydr Res; 1987 Nov; 169():69-81. PubMed ID: 3427590 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of sugar-ring hydroxyl analogues of daunorubicin. Fuchs EF; Horton D; Weckerle W; Winter-Mihaly E J Med Chem; 1979 Apr; 22(4):406-11. PubMed ID: 571021 [TBL] [Abstract][Full Text] [Related]
11. Adriamycin analogues. Preparation and biological evaluation of some novel 14-thiaadriamycins. Seshadri R; Israel M; Pegg WJ J Med Chem; 1983 Jan; 26(1):11-5. PubMed ID: 6827523 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumour activity of new daunorubicin and adriamycin analogues. Arcamone F; Bernardi L; Patelli B; Giardino P; Di Marco A; Casazza AM; Soranzo C; Pratesi G Experientia; 1978 Oct; 34(10):1255-7. PubMed ID: 570116 [TBL] [Abstract][Full Text] [Related]
13. Effect of various substitutions in positions 1, 2, 3, and 4 of 4-demethoxydaunorubicin and 4-demethoxyadriamycin. Di Marco A; Casazza AM; Soranzo C; Pratesi G Cancer Chemother Pharmacol; 1978; 1(4):249-54. PubMed ID: 750112 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity of 7-O-[2,6-dideoxy-2-fluoro-5-C-(trifluoromethyl)-alpha-L-talopyranosyl]- daunomycinone and -adriamycinone. Nakai K; Takagi Y; Tsuchiya T Carbohydr Res; 1999 Mar; 316(1-4):47-57. PubMed ID: 10420587 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological and biochemical properties of new anthracyclines modified in the aminosugar moiety. Bargiotti A; Casazza AM; Cassinelli G; Di Marco A; Penco S; Pratesi G; Supino R; Zaccara A; Zunino F; Arcamone F Cancer Chemother Pharmacol; 1983; 10(2):84-9. PubMed ID: 6831630 [TBL] [Abstract][Full Text] [Related]
16. N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin. Israel M; Modest EJ; Frei E Cancer Res; 1975 May; 35(5):1365-8. PubMed ID: 1054622 [TBL] [Abstract][Full Text] [Related]
17. Adriamycin analogues. Preparation of 9,10-anhydrodaunorubicin, 9,10-anhydroadriamycin, and some related compounds. Potti G; Israel M J Med Chem; 1982 Apr; 25(4):478-81. PubMed ID: 6951049 [TBL] [Abstract][Full Text] [Related]
18. Adriamycin analogs. Periodate oxidation of adriamycin. Tong G; Lee WW; Black DR; Henry DW J Med Chem; 1976 Mar; 19(3):395-8. PubMed ID: 176359 [TBL] [Abstract][Full Text] [Related]
19. Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression. Schwartz HS; Grindey GB Cancer Res; 1973 Aug; 33(8):1837-44. PubMed ID: 4720795 [No Abstract] [Full Text] [Related]
20. Adriamycin analogues. rationale, synthesis, and preliminary antitumor evaluation of highly active DNA-nonbinding N-(trifluoroacetyl)adriamycin 14-O-hemiester derivatives. Israel M; Potti PG; Seshadri R J Med Chem; 1985 Sep; 28(9):1223-8. PubMed ID: 3839851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]